Bridgepoint Group (LON:BPT – Get Free Report)‘s stock had its “buy” rating reiterated by Berenberg Bank in a research report issued to clients and investors on Friday,London Stock Exchange reports. They currently have a GBX 360 price objective on the stock. Berenberg Bank’s target price suggests a potential upside of 12.15% from the company’s previous close.
Separately, Citigroup cut their target price on Bridgepoint Group from GBX 415 to GBX 395 and set a “buy” rating for the company in a research note on Tuesday, April 14th. Three research analysts have rated the stock with a Buy rating, According to MarketBeat.com, Bridgepoint Group has an average rating of “Buy” and a consensus price target of GBX 390.
View Our Latest Analysis on Bridgepoint Group
Bridgepoint Group Stock Up 1.8%
About Bridgepoint Group
Bridgepoint Group plc is a private equity and private credit firm specializing in middle market, small mid cap, small cap, growth capital, buyouts investments, syndicate debt, infrastructure, direct lending and credit opportunities in private credit investments. It prefers to invest in advanced industrials, automation, agricultural sciences, energy transition enablers, business services, financial services, professional services, testing inspection and certification, information services, consumer, digital brands, video games, wellbeing products, health care, pharma and MedTech outsourced services, pharma products, and MedTech Products sectors.
Further Reading
- Five stocks we like better than Bridgepoint Group
- Premium Retail’s Stress Test Is Separating Winners From Losers
- D-Wave Quantum or a Quantum ETF: Which Is the Better Bet?
- GE Vernova Just Sent a Mixed AI Signal to Investors
- Alphabet Crushed Earnings, But One Number Spooked the Market
Receive News & Ratings for Bridgepoint Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bridgepoint Group and related companies with MarketBeat.com's FREE daily email newsletter.
